Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication September 29, 2011
- Accepted for publication September 29, 2011
- Published online November 1, 2011.
Copyright & Usage
© 2011 by Society of Nuclear Medicine
Author Information
- Eleni Gourni1,
- Oliver Demmer2,
- Margret Schottelius1,
- Calogero D'Alessandria3,
- Stefan Schulz4,
- Ingrid Dijkgraaf3,
- Udo Schumacher5,
- Markus Schwaiger3,
- Horst Kessler2,6 and
- Hans-Jürgen Wester1
- 1Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany
- 2Institute for Advanced Study, Technische Universität München, Garching, Germany
- 3Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Germany
- 4Institut für Pharmakologie und Toxikologie, Universitätsklinikum Jena, Jena, Germany
- 5Institute for Anatomy II, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; and
- 6Chemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
- For correspondence and reprints contact: Hans-Jürgen Wester, Pharmaceutical Radiochemistry, Technische Universität München, Meissner-Strasse 3, D-85748 Garching, Germany. E-mail: h.j.wester{at}tum.de
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma
- High CXCR4 expression in adenoid cystic carcinoma of the head and neck is associated with increased risk of locoregional recurrence
- 64Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist
- Radionuclide Image-Guided Repair of the Heart
- Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation
- Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma
- CXCR4 Is a Potential Target for Diagnostic PET/CT Imaging in Barrett's Dysplasia and Esophageal Adenocarcinoma
- 68Ga-Pentixafor PET/CT Imaging of Chemokine Receptor CXCR4 in Chronic Infection of the Bone: First Insights
- Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque Using 68Ga-Pentixafor PET: Correlation with Cardiovascular Risk Factors and Calcified Plaque Burden
- Integrating MRI and Chemokine Receptor CXCR4-Targeted PET for Detection of Leukocyte Infiltration in Complicated Urinary Tract Infections After Kidney Transplantation
- CXCR4 Ligands: The Next Big Hit?
- Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET
- Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
- The Role of Attractiveness: Imaging the Interaction Between Cardiovascular and Immune System
- First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers
- First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
- Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction
- [68Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction
- Biodistribution and Radiation Dosimetry for the Chemokine Receptor CXCR4-Targeting Probe 68Ga-Pentixafor